This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Fuso Pharmaceutical Industries, Ltd., Hokkaido University, Nb Health Laboratory Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023-2026
Title: Miki Nakagawa: Innovator in Biotechnology
Introduction
Miki Nakagawa is a prominent inventor based in Hokkaido, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for mammalian cells. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing scientific research.
Latest Patents
Miki Nakagawa holds 2 patents, with her latest invention focusing on an antibody, nucleic acid, cell, and pharmaceutical. This patent describes a vector that includes a translation-impaired dihydrofolate reductase gene cassette and a ubiquitously acting chromatin opening element. The invention provides mammalian cell expression vectors that enable host cells to produce high levels of foreign gene-derived proteins. By introducing a ubiquitously acting chromatin opening element into an expression vector, the invention allows for the selection of strains that can grow in hypoxanthine-thymidine-free medium, resulting in increased production of the desired protein.
Career Highlights
Throughout her career, Miki Nakagawa has worked with esteemed institutions such as Hokkaido University and Fuso Pharmaceutical Industries, Ltd. Her experience in these organizations has contributed to her development as a leading figure in her field.
Collaborations
Miki has collaborated with notable colleagues, including Tomohiro Okagawa and Kazuhiko Ohashi. These partnerships have further enriched her research and innovation efforts.
Conclusion
Miki Nakagawa's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the field, paving the way for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile